Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Massachusetts Institute of Technology, U.S.
Findings reported by Massachusetts Institute of Technology, U.S., further disease research
February 14th, 2007
Findings reported by Massachusetts Institute of Technology, U.S., further disease research. This trend article about Massachusetts Institute of Technology, U.S., is an immediate alert from NewsRx to identify developing directions of research. Study 1: A report, "Antisense transcription controls cell fate in Saccharomyces cerevisiae," is newly published data in Cell. "Entry into meiosis is a key developmental decision. We show here that meiotic entry in Saccharomyces cerevisiae is controlled by antisense-mediated regulation of IME4, a gene required for initiating meiosis," investigators in the United States report. "In MAT...
Source: Medical Patent Law Weekly (2007-02-14)
|
